2026-07-25 2026-07-25 , online online, 390 € zzgl. MwSt. Anna Wehage https://forum-institut.de/seminar/26122663-recording-update-eu-pharma-legislation-supply-shortages-and-supply-security/referenten/26/26_12/26122663-recording-update-eu-pharma-legislation-supply-shortages-and-supply-security_wehage-anna.jpg Recording: Update EU Pharma Legislation - Supply shortages and supply security

This recording delivers a clear overview of the new supply shortage obligations under the EU pharma reform. In approximately 90 minutes, you will understand the new prevention and risk planning requirements, the coordination between EMA and national competent authorities, and the practical implications for manufacturers and marketing authorisation holders.

Topics
  • New obligations for shortage prevention and risk planning
  • Coordination between the EMA, national competent authorities (NCAs), and pharmaceutical companies
  • Reporting and monitoring obligations, EU mechanisms for shortage analysis
  • Practical implications for manufacturers, marketing authorisation holders, and supply chain management
  • Interplay with the Critical Medicines Act


Who should attend
This course is designed for regulatory affairs professionals with a solid background in EU marketing authorisation procedures. Legal/compliance, quality, pharmacovigilance and related professionals involved in planning and implementing EU regulatory requirements will also benefit from this recording.
Aims and objectives
This recording of a live webcast series provides a structured, practice-oriented update on the EU pharmaceutical reform. The webcast consists of four individual modules, each approximately 90 minutes long, which are available separately or as a complete bundle at a reduced price. This course covers one module. The bundle "Update EU Pharma Legislation - The Full Series" can be found via the webcode 60012660.

The recording of this module provides a structured overview of the new supply shortage obligations under the EU pharmaceutical reform. In approximately 90 minutes, you will gain clarity on the new requirements for shortage prevention and risk planning, the coordination mechanisms between EMA, national competent authorities and pharmaceutical companies, and the reporting and monitoring obligations introduced by the reform. The module also addresses the practical implications for manufacturers, marketing authorisation holders and supply chain management, as well as the interplay with the Critical Medicines Act. By the end, you will be able to assess the operational impact of the new shortage framework on your organisation and identify the measures needed to ensure compliance.

The recorded content is available to you flexibly - ideal for reviewing the topics at your own pace or looking up specific sections as needed. Access to the recording is available for 90 days after purchase.
Your benefit

  • Recording of a live webcast - for maximum flexibility and self-paced learning
  • Concise 90-minute format covering supply shortage obligations and supply security
  • Clear overview of new prevention and risk planning requirements
  • Guidance on reporting and monitoring obligations
  • Insights on the practical implications for manufacturers and MAHs
  • Understanding of the interplay with the Critical Medicines Act

Recording: Update EU Pharma Legislation - Supply shortages and supply security

Recording: Update EU Pharma Legislation - Supply shortages and supply security

Benefits
  • Flexible format
  • Concise update in approximately 90 minutes
  • Complete webcast available at reduced price
  • Officially certified according to ISO 9001 and ISO 21001

Webcode 26122663

Jetzt buchen

JETZT Buchen

Referent


Gebühr
Ihre Kontaktperson

Jean-Marie Bayhurst
Konferenzmanager Pharma & Healthcare

+49 6221 500-685
j.bayhurst@forum-institut.de

Details

This recording delivers a clear overview of the new supply shortage obligations under the EU pharma reform. In approximately 90 minutes, you will understand the new prevention and risk planning requirements, the coordination between EMA and national competent authorities, and the practical implications for manufacturers and marketing authorisation holders.

Topics

  • New obligations for shortage prevention and risk planning
  • Coordination between the EMA, national competent authorities (NCAs), and pharmaceutical companies
  • Reporting and monitoring obligations, EU mechanisms for shortage analysis
  • Practical implications for manufacturers, marketing authorisation holders, and supply chain management
  • Interplay with the Critical Medicines Act


Who should attend
This course is designed for regulatory affairs professionals with a solid background in EU marketing authorisation procedures. Legal/compliance, quality, pharmacovigilance and related professionals involved in planning and implementing EU regulatory requirements will also benefit from this recording.

Aims and objectives

This recording of a live webcast series provides a structured, practice-oriented update on the EU pharmaceutical reform. The webcast consists of four individual modules, each approximately 90 minutes long, which are available separately or as a complete bundle at a reduced price. This course covers one module. The bundle "Update EU Pharma Legislation - The Full Series" can be found via the webcode 60012660.

The recording of this module provides a structured overview of the new supply shortage obligations under the EU pharmaceutical reform. In approximately 90 minutes, you will gain clarity on the new requirements for shortage prevention and risk planning, the coordination mechanisms between EMA, national competent authorities and pharmaceutical companies, and the reporting and monitoring obligations introduced by the reform. The module also addresses the practical implications for manufacturers, marketing authorisation holders and supply chain management, as well as the interplay with the Critical Medicines Act. By the end, you will be able to assess the operational impact of the new shortage framework on your organisation and identify the measures needed to ensure compliance.

The recorded content is available to you flexibly - ideal for reviewing the topics at your own pace or looking up specific sections as needed. Access to the recording is available for 90 days after purchase.

Your benefit

  • Recording of a live webcast - for maximum flexibility and self-paced learning
  • Concise 90-minute format covering supply shortage obligations and supply security
  • Clear overview of new prevention and risk planning requirements
  • Guidance on reporting and monitoring obligations
  • Insights on the practical implications for manufacturers and MAHs
  • Understanding of the interplay with the Critical Medicines Act

Programm

Anna Wehage

Supply shortages and supply security
  • New obligations for shortage prevention and risk planning
  • Coordination between the EMA, national competent authorities (NCAs), and pharmaceutical companies
  • Reporting and monitoring obligations, EU mechanisms for shortage analysis
  • Practical implications for manufacturers, marketing authorisation holders, and supply chain management
  • Interplay with the Critical Medicines Act

Further details

Content

Supply shortages and supply security This course is a recorded module from a live webcast series held in June 2026. You will gain access to all content flexibly - ideal to go through the topics at your own pace or revisit specific sections as needed. Access to the recording is available for 90 days after purchase. The content reflects the status at the time of the event.

Complete Webcast Bundle

This module is also available as part of the complete four-module bundle “Update EU Pharma Legislation – The Full Series“ at a reduced price.

The bundle includes the following modules:
  • The legal framework part 1 - overview and current procedural status
  • The legal framework part 2 - protection periods
  • Supply shortages and supply security
  • Environmental Risk Assessment (ERA)

More information can be found via the webcode 60012660.

This distinguishes our events

of 5 stars of all ratings from 2025

of 5 stars on Trustpilot = good

Recommendations

Hot Topics Regulatory Affairs

Diese Online-Tagung bietet einen umfassenden Einblick in die neusten Entwicklungen der EU-Pharmagesetzgebung, Variation ...

26. - 27.08.2026 in
Details

Global variations and lifecycle management

Global variations and lifecycle management - covering key regions: USA, Asia (China, Japan, South Korea), LATAM (Central...

31.08. - 21.09.2026 in
Details

Regulatory Affairs and GMP compliance in Eastern Europe

This online training offers comprehensive insights into Regulatory Affairs, CMC, and GMP requirements, with a focus on t...

26. - 27.08.2026 in
Details

Prozessvalidierung - Anforderungen an CMC-Daten

Prozessvalidierung - Das Intensivseminar zu den aktuellen regulatorischen Anforderungen. Sichern Sie sich jetzt Ihren Pl...

25.08.2026 in
Details

EU-Arzneimittelzulassung für Einsteiger*innen

In diesem Seminar erhalten Sie Know-how zur Zulassung von Arzneimitteln in Europa. Sie lernen, welche Zulassungswege mög...

25. - 28.08.2026 in
Details

Go forward

DEMO-Account e-Learning

Try out our e-Learning programmes free of charge and without any obligation.

Details
DEMO-Account e-Learning
We guarantee the highest quality

We are now officially certified to ISO 9001 and ISO 21001 standard.

Details
We guarantee the highest quality
Our rating in 2025

More than 3,700 customers have rated our training courses. Thank you for awarding us 4.4 stars out of 5.

Details
Our rating in 2025